.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Johnson and Johnson
Accenture
AstraZeneca
Federal Trade Commission
Fish and Richardson
Medtronic
McKesson
Merck
McKinsey

Generated: January 23, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: guanfacine hydrochloride

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Actavis ElizabethGUANFACINE HYDROCHLORIDEguanfacine hydrochlorideTABLET, EXTENDED RELEASE;ORAL200881ANDAActavis Pharma, Inc.0228-2850-11100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-2850-11)
Actavis ElizabethGUANFACINE HYDROCHLORIDEguanfacine hydrochlorideTABLET, EXTENDED RELEASE;ORAL200881ANDAActavis Pharma, Inc.0228-2850-50500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-2850-50)
Actavis ElizabethGUANFACINE HYDROCHLORIDEguanfacine hydrochlorideTABLET, EXTENDED RELEASE;ORAL200881ANDAActavis Pharma, Inc.0228-2851-50500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-2851-50)
Actavis ElizabethGUANFACINE HYDROCHLORIDEguanfacine hydrochlorideTABLET, EXTENDED RELEASE;ORAL200881ANDAActavis Pharma, Inc.0228-2851-11100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-2851-11)
Actavis ElizabethGUANFACINE HYDROCHLORIDEguanfacine hydrochlorideTABLET, EXTENDED RELEASE;ORAL200881ANDAActavis Pharma, Inc.0228-2853-11100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-2853-11)
Actavis ElizabethGUANFACINE HYDROCHLORIDEguanfacine hydrochlorideTABLET, EXTENDED RELEASE;ORAL200881ANDAActavis Pharma, Inc.0228-2853-50500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-2853-50)
Actavis ElizabethGUANFACINE HYDROCHLORIDEguanfacine hydrochlorideTABLET, EXTENDED RELEASE;ORAL200881ANDAActavis Pharma, Inc.0228-2855-11100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-2855-11)
Actavis ElizabethGUANFACINE HYDROCHLORIDEguanfacine hydrochlorideTABLET, EXTENDED RELEASE;ORAL200881ANDAActavis Pharma, Inc.0228-2855-50500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0228-2855-50)
Actavis ElizabethGUANFACINE HYDROCHLORIDEguanfacine hydrochlorideTABLET, EXTENDED RELEASE;ORAL200881ANDAAvKARE, Inc.42291-324-01100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-324-01)
Actavis ElizabethGUANFACINE HYDROCHLORIDEguanfacine hydrochlorideTABLET, EXTENDED RELEASE;ORAL200881ANDAAvKARE, Inc.42291-325-01100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-325-01)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
Chubb
Johnson and Johnson
Express Scripts
Cantor Fitzgerald
Argus Health
Queensland Health
QuintilesIMS
Healthtrust
Chinese Patent Office

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot